HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Peculiarities of ECG in patients with phenothiazine-induced cardiomyopathy].

Abstract
Ten most common and clinically significant pathological changes of ECG in schizophrenic patients with and without phenothiazine-induced cardiomyopathy (PCMP) at different stages of neuroleptic therapy are considered. A total of 46 men and 10 women were available for observation. The results of ECG studies in schizophrenics with PCMP and psychically healthy patients with DCMP were virtually identical. Dynamics of certain characteristics was shown to be of value for early diagnostics of phenothiazine cardiotoxic side-effects. These data confirm the advisability of regarding PCMP as a separate nosological entity in the group of seconfary cardiomyopathies.
AuthorsV P Volkov
JournalKlinicheskaia meditsina (Klin Med (Mosk)) Vol. 89 Issue 4 Pg. 27-30 ( 2011) ISSN: 0023-2149 [Print] Russia (Federation)
PMID21932558 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Antipsychotic Agents
  • Phenothiazines
  • phenothiazine
Topics
  • Adult
  • Antipsychotic Agents (adverse effects, therapeutic use)
  • Cardiomyopathies (chemically induced, diagnosis, physiopathology)
  • Electrocardiography
  • Female
  • Humans
  • Male
  • Middle Aged
  • Phenothiazines (adverse effects, therapeutic use)
  • Schizophrenia (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: